(19)
(11) EP 0 927 024 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
31.08.2005 Bulletin 2005/35

(45) Mention of the grant of the patent:
25.05.2005 Bulletin 2005/21

(21) Application number: 97916936.4

(22) Date of filing: 24.03.1997
(51) International Patent Classification (IPC)7A61K 9/00, A61P 27/02
(86) International application number:
PCT/US1997/004701
(87) International publication number:
WO 1997/034586 (25.09.1997 Gazette 1997/41)

(54)

DEVICE AND METHOD FOR TREATING OPHTHALMIC DISEASES

APPARAT UND VERFAHREN ZUR BEHANDLUNG VON AUGENERKRANKUNGEN

DISPOSITIF ET METHODE DE TRAITEMENT DE MALADIES OPHTALMIQUES


(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 22.03.1996 US 620982

(43) Date of publication of application:
07.07.1999 Bulletin 1999/27

(60) Divisional application:
05010733.3

(73) Proprietor: Neurotech S.A.
75571 Paris Cedex 12 (FR)

(72) Inventors:
  • SPEAR, Peter, D.
    Madison, WI 53713 (US)
  • HAMMANG, Joseph, P.
    Barrington, RI 02806 (US)
  • BAETGE, E., Edward
    Barrington, RI 02806 (US)
  • TSIARAS, William, G.
    Barrington, RI 02806 (US)

(74) Representative: Crump, Julian Richard John et al
Mintz Levin Cohn Ferris Glovsky and Popeo Intellectual Property LLP The Rectory 9, Ironmonger Lane
London EC2V 8EY
London EC2V 8EY (GB)


(56) References cited: : 
WO-A-95/13765
WO-A-95/28166
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).